ArticleJournal for immunotherapy of cancer2026

Engineering T cell-engaging bispecific antibodies targeting KRAS G12V neoantigen across HLA-A*11:01 and HLA-A*03:01.

Xiaojing Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.